Ashok Iyaswamy

2.7k citations
64 papers · 2.1k indexed · h-index 28
Topics
Alzheimer's disease research and treatments (24 papers)Autophagy in Disease and Therapy (20 papers)Cholinesterase and Neurodegenerative Diseases (11 papers)
Partner nations
Hong KongIndiaChina

In The Last Decade

Ashok Iyaswamy

62 papers receiving 2.1k citations

Peers

Ashok Iyaswamy
Comparison fields: 5 of 117
  • Molecular Biology 731
  • Physiology 669
  • Epidemiology 523
  • Pharmacology 313
  • Neurology 243
Replace Chuanbin Yang with:
Chuanbin Yang China
Koji Fukui Japan
Sravan Gopalkrishnashetty Sreenivasmurthy Hong Kong
Chih‐Li Lin Taiwan
Bing Gong China
Marı́a F. Galindo Spain
Haiyan Lou China
Ju‐Xian Song Hong Kong
Guylène Page France
Ashok Iyaswamy relative to Chuanbin Yang China Chuanbin Yang's profile →
Citations per field
00.5×1.5×
Chuanbin Yang · 1×
Citations per year

Countries citing papers authored by Ashok Iyaswamy

Since Specialization
Citations

This map shows the geographic impact of Ashok Iyaswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Iyaswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Iyaswamy more than expected).

Fields of papers citing papers by Ashok Iyaswamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Iyaswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Iyaswamy. The network helps show where Ashok Iyaswamy may publish in the future.

Co-authorship network of co-authors of Ashok Iyaswamy

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Iyaswamy. A scholar is included among the top collaborators of Ashok Iyaswamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Iyaswamy. Ashok Iyaswamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 6
5 9
6 12
7 13
8 1
9 15
10 21
11 30
12 38
13 44
14 39
15 45
16 26
17 31
18 35
19 34
20 30

About Ashok Iyaswamy

Ashok Iyaswamy is a scholar working on Physiology, Pharmacology and Physiology, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (24 papers), Autophagy in Disease and Therapy (20 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). The work is most often cited by research in Biological Psychiatry (102 citations), Neurology (243 citations) and Physiology (119 citations). Ashok Iyaswamy has collaborated with scholars based in Hong Kong, India and China. Frequent co-authors include Min Li, Rathinasamy Sheeladevi, Sravan Gopalkrishnashetty Sreenivasmurthy, Ju‐Xian Song, Zhou Zhu, King‐Ho Cheung, Jiahong Lu, Jia Liu, Cheng-Fu Su and Benjamin Chun‐Kit Tong. Their work appears in journals such as Analytical Chemistry, Scientific Reports and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026